Industry reports
Editor highlights

Publication dates

data types

Biotherapeutics Market and Forecasts, April 2014

You might be interested in: biosimilar, bioprocessing, protein, more »

1-10 of 91 reports for Biotherapeutics

Biosimilar Market Analysis in The United States and Japan

  • Industry report
  • May 2013
  • 62 pages

... Management plan is fundamental for all biotherapeutic products since even minor differences in the manufacturing process may affect the efficacy and/or safety profile Innovator products Biosimilar may ...

Blood Sector in Canada

  • Industry report
  • April 2012
  • 3 pages

... Products manufactured by grifols (formerly talecris biotherapeutics), csl behring and baxter corporation to meet the expected demand for this year. Purchasing immune globulin products from multiple ...

The Chinese Biopharmaceutical Business : Innovation and Technology Trends

  • Industry report
  • March 2012
  • 10 pages

... Koenig, ceo, macrogenics 1530 afternoon tea break biotherapeutics closing plenary workshop 1600-1700 glycosylation as a strategy to improve antibody-based therapeutics to date, more than 20 ...

Blood Product Business in Italy and The United States

  • Industry report
  • August 2012
  • 2 pages

... That grifols will exit the melville factory in about two years. Grifols, based in barcelona, spain, sold the plant to satisfy federal antitrust concerns over its 2011 merger with talecris biotherapeutics ...

Industry report on Biosimilar and Biologic Medicine in The United States

  • Industry report
  • February 2012
  • 62 pages

... biotherapeutic product. (8) The european medicines agency: a biological medicine that is developed to be similar to an existing biological medicine (the Reference medicine ). When approved, a biosimilar ...

Pharmaceutical Business in Australia and The United States

  • Industry report
  • October 2012
  • 32 pages

... Company headquartered in australia. As a leader in personalized bio-therapeutic products for cancer, prima is dedicated to leveraging its current technology and expertise to develop innovative treatment ...

Biosimilar Business in Iran and South Korea

  • Industry report
  • May 2012
  • 8 pages

... Pdf. 7. Wadhwa m, kang hn, knezevic i, thorpe r, griffiths e: who/kfda joint workshop on implementing who guidelines on evaluating similar biotherapeutic products, seoul, republic of korea 24 26 August ...

Genomics Sector in India

  • Industry report
  • January 2012
  • 32 pages

... Therapy Growing market size Patent cliff on key biosimilar products: as many as 30 biotherapeutics totaling $51 billion in sales are set to lose patent exclusivity by 2015. This will make ...

Drug in Canada and The United States : Innovation and Technology Trends

  • Industry report
  • February 2012
  • 5 pages

... biotherapeutic products: chemistry, manufacturing, and control (cmc) information, Intended to provide recommendations regarding cmc data which should be included in investigational new drug (ind) applications ...

Biopharmaceutical in China and Germany : Innovation and Technology Trends

  • Industry report
  • December 2012
  • 5 pages

... Over the past ten years. In the meantime there is a wide variety of products available. Most single- use products are found in processes where protein-based biotherapeutics made from mammalian cells ...

» Purchase Premium Reports (From $ 55 - $ 4 600)

About 200 reports for Biotherapeutics
Protalix Biotherapeutics Inc

Protalix Biotherapeutics Inc

  • $ 55
  • Company report
  • April 2014
  • by Wright Investors' Service

A textual analysis of the financial results for Protalix Biotherapeutics Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ...

Manhattan Scientifics, Inc.

April 2014 $ 55

Halozyme Therapeutics, Inc.

April 2014 $ 55

» Read our Company Profiles

2 Companies for Biotherapeutics


United States

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.